Redunction of mechanical heart valve thrombosis through a clinical audit

Journal of Heart Valve Disease

Volumn 12, Issue 3, 2003, Pages 362-369

  Bharat, V ^a   Das, N K ^a   Mohanty, B ^a   Jha, A C ^a   Chawla, S C ^a   Dash, B ^a   Mohanty, R ^a  

^a Manipal Tata Medical College Jamshedpur   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN ANTICOAGULANT; FIBRINOLYTIC AGENT; RIFAMPICIN; VITAMIN K GROUP; WARFARIN;

ABDOMINAL BLEEDING; ANTICOAGULATION; ARTICLE; BJOERK SHILEY VALVE PROSTHESIS; BLEEDING; BRAIN INFARCTION; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG INHIBITION; DYSPNEA; EARLY DIAGNOSIS; FEMALE; FIBRINOLYSIS; FOLLOW UP; FOOD DRUG INTERACTION; HEALTH CARE DELIVERY; HEART MURMUR; HEART VALVE PROSTHESIS; HUMAN; INCIDENCE; INDIA; INTERNATIONAL STANDARD UNIT; INTRACARDIAC THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT EDUCATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; SAINT JUDE HEART VALVE PROSTHESIS; STARR EDWARDS VALVE PROSTHESIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; VALVULAR HEART DISEASE; ADULT; AGED; AORTA VALVE; BIOPROSTHESIS; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; HEART VALVE REPLACEMENT; METHODOLOGY; MIDDLE AGED; MITRAL VALVE; MORTALITY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROSTHESIS FAILURE; REFERENCE VALUE; SURVIVAL; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INDIA; MALE; MEDICAL AUDIT; MIDDLE AGED; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0038312990     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wernly JA, Crawford MH. Choosing a prosthetic heart valve. Cardiol Clin 1991;9:329-338
2. Cannegieter S, Rosendall F, Wintzen A, Van Der Meer F, Vandenbroucke, Briet E. Optimum oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17
3. Balram A, Kaul U, RamaRao BV, et al. Thrombotic obstruction of Björk-Shiley valves: Diagnostic and surgical considerations. Int J Cardiol 1984;6:61-73
4. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years heart valve replacement with a mechanical valve or bio-prosthesis. N Engl J Med 1993;328:1289-1296
5. Watts EJ. Audit of anticoagulant control experience in three regions. Proceedings of the 5th User Group Meeting of Dawn AC, 1997
6. Johnson D. Audit in surgery. In: Bailey and Love's Short Practice of Surgery, 23rd edn. Arnold Publishers, 2000:1307-1313
7. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interaction of warfarin with drugs and food. Ann Intern Med 1994;121:676-683
8. Bharat V. Mechanical heart valves: An insight into thrombotic complications. Ind Heart J 1999;51:59-63
9. Florell SR, Rodgers GM, III. The PT and the pendulum. Am J Clin Pathol 1996;106:699-700
10. Critchfield GC, Bennett ST, Swaim WR. Calibration verification of the International Normalized Ratio. Am J Clin Pathol 1996;106:786-794
11. Johnston M, Brigden M. For the Thrombosis Interest Group of Canada. Does the establishment of local ISI values improve the accuracy of the international normalized ratio? Am J Clin Pathol 1998;110:683-690
12. Spandorfer JM. Outpatient anticoagulant issues for the primary care physician. Med Clin N Am 1996;80:475-491
13. Freedman MD, Olatidoye AG. Clinically significant drug interactions with oral anticoagulants. Drug Safety 1994;10:381-394
14. Laurence DR, Bennett ST, Brown MJ. Drugs and haemostasis. In: Clinical Pharmacology, 8th edn. Churchill Livingstone, 1997:519-523
15. Hirsh J. Is the dose of warfarin prescribed by American physicians unnecessarily high? Arch Intern Med 1987;147:769-771
16. Saour JN, Sieck JO, Mamo LAR, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990;322:428-432
17. Guidelines on oral anticoagulation. 3rd edn. Prepared by the Haemostasis and Thrombosis Task Force for the British Committee for Standards in Hematology. Br J Haematol 1998;101:374-387
18. Fihn SD. Aiming for safe anticoagulation. N Engl J Med 1995;333:54-55
19. Rajasekhar D, Balakrishnan KG, Venkitachalam CG, et al. Thrombolytic therapy for prosthetic cardiac valve thrombosis. Ind Heart J 1994;46:101-105
20. Agarwal D, Dubey S, Saket B, et al. Thrombolytic therapy for prosthetic valve thrombosis in third world countries. Ind Heart J 1997;49:383-386
21. Roudat R, Labbe T, Lorient-Roudat MF, et al. Mechanical cardiac valve thrombosis: Is thrombolysis justified? Circulation 1992;86(suppl.II):8-15
22. Bharat V, Gondal PK, Das NK, Mohanty B. Acute abdomen caused by anticoagulants. A report of three cases. J Assoc Surg India 2000;62:401-403
23. Edmund LH, Jr. Thrombotic and bleeding complications of cardiac valvular prostheses. Thorac Surg 1987;44:430-445
24. Kontos GH, Schaff HV, Orszulak TA, Puga FJ, Pluth JR, Danielson GK. Thrombotic obstruction of disc valves: Clinical recognition and surgical management. Ann Thorac Surg 1989;48:60-65
25. Butchart EG. Thrombogenicity, thrombosis and embolism: Current issues in heart valve disease-Thrombosis, embolism and bleeding. ICR Publishers, London, 1992:293